F943-1326 Screening compound: 6-{1,4-dioxa-8-azaspiro[4.5]decane-8-sulfonyl}-3-[2-(morpholin-4-yl)-2-oxoethyl]-2,3-dihydro-1,3-benzothiazol-2-one

F943-1326 Screening compound: 6-{1,4-dioxa-8-azaspiro[4.5]decane-8-sulfonyl}-3-[2-(morpholin-4-yl)-2-oxoethyl]-2,3-dihydro-1,3-benzothiazol-2-one
F943-1326 Screening compound: 6-{1,4-dioxa-8-azaspiro[4.5]decane-8-sulfonyl}-3-[2-(morpholin-4-yl)-2-oxoethyl]-2,3-dihydro-1,3-benzothiazol-2-one alternative view

Chemical Structure Depiction of ChemDiv screening compound F943-1326
6-{1,4-dioxa-8-azaspiro[4.5]decane-8-sulfonyl}-3-[2-(morpholin-4-yl)-2-oxoethyl]-2,3-dihydro-1,3-benzothiazol-2-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F943-1326

Molecular Formula

C20H25N3O7S2 (C20 H25 N3 O7 S2)

Compound Name

6-{1,4-dioxa-8-azaspiro[4.5]decane-8-sulfonyl}-3-[2-(morpholin-4-yl)-2-oxoethyl]-2,3-dihydro-1,3-benzothiazol-2-one

IUPAC name

6-{14-dioxa-8-azaspiro[4.5]decane-8-sulfonyl}-3-[2-(morpholin-4-yl)-2-oxoethyl]-23-dihydro-13-benzothiazol-2-one

SMILES

O=C(CN(c(ccc(S(N(CC1)CCC11OCCO1)(=O)=O)c1)c1S1)C1=O)N1CCOCC1

InChI

InChI=1S/C20H25N3O7S2/c24-18(21-7-9-28-10-8-21)14-23-16-2-1-15(13-17(16)31-19(23)25)32(26,27)22-5-3-20(4-6-22)29-11-12-30-20/h1-2,13H,3-12,14H2

InChI Key

WFSTZCNKSJQAMN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27205290

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

483.57

Hydrogen Bond Acceptors Count

13.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

0.921

Distribution Coefficient, logD

0.921

Water Solubility, LogSw

-2.34

Polar Surface Area

86.260

Acid Dissociation Constant (pKa)

21.85

Base Dissociation Constant (pKb)

-0.89

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

60.00

F943-1326 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F943-1326 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F943-1326?
Check Price and Availability of F943-1326, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F943-1326 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F943-1326
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F943-1326
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F943-1326 available by request